Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

about

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

Item

http://www.wikidata.org/entity/Q49164867

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

@en

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

@nl

type

Item

label

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

@en

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

@nl

prefLabel

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

@en

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

@nl

P1476

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

@en

P2093

Camila Bonemann Bender

http://www.w3.org/2001/XMLSchema#string

Fabiana Kömmling Seixas

http://www.w3.org/2001/XMLSchema#string

Julieti Huch Buss

http://www.w3.org/2001/XMLSchema#string

Karine Rech Begnini

http://www.w3.org/2001/XMLSchema#string

Silvia S Guterres

http://www.w3.org/2001/XMLSchema#string

Tiago Collares

http://www.w3.org/2001/XMLSchema#string

P2860

Small dsRNAs induce transcriptional activation in human cells

Nanomedicine concepts in the general medical curriculum: initiating a discussion

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Bladder cancer: narrowing the gap between evidence and practice

Nanomedicine: techniques, potentials, and ethical implications.

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.

Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105).

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin

P304

977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2017.00977

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adriana R. Pohlmann

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29379438

http://www.w3.org/2001/XMLSchema#string

P932

5770893

http://www.w3.org/2001/XMLSchema#string